At the 10th anniversary celebration of NTC, Marcello Selvaggio, the company's Global Head of Business Franchise Ophthalmology, recounted one of the company's key achievements in ophthalmology innovation. "It's a therapeutic combination developed in Italy to combat inflammation in patients undergoing cataract surgery. We've begun to market this product worldwide, and it's now available in 90 countries.
This is a great success for our country."
https://www.youtube.com/watch?v=SdspPV07pqA
